Legal & General Group PLC Neu Base Therapeutics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.63 - $7.34 $9,162 - $14,525	-1,979 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.92 - $12.36 $1,328 - $2,373	-192 Reduced 8.84%	1,979 $15,000
Q3 2020 Nov 13, 2020	SELL	$7.25 - $9.71 $4,893 - $6,554	-675 Reduced 23.72%	2,171 $16,000
Q2 2020 Aug 14, 2020	BUY	$6.69 - $11.51 $19,039 - $32,757	2,846 New	2,846 $25,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.